000 04738nam a22006255i 4500
001 978-3-031-63118-4
003 DE-He213
005 20251030113247.0
007 cr nn 008mamaa
008 241027s2024 sz | s |||| 0|eng d
020 _a9783031631184
_9978-3-031-63118-4
024 7 _a10.1007/978-3-031-63118-4
_2doi
050 4 _aQR180-189.5
072 7 _aMJCM
_2bicssc
072 7 _aMED044000
_2bisacsh
072 7 _aMJCM
_2thema
245 1 0 _aHuman Challenge Studies for Vaccine Development
_h[electronic resource] /
_cedited by Fabio Bagnoli, Giuseppe Del Giudice, Sanjay K. Phogat, Rino Rappuoli.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aVIII, 377 p. 40 illus., 25 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCurrent Topics in Microbiology and Immunology,
_x2196-9965 ;
_v445
505 0 _aA brief history of human challenge studies (1900-2021) emphasising the virology, regulatory and ethical requirements, raison d’etre, ethnography, selection of volunteers and unit design -- Regulatory aspects of human challenge studies.-Controlled Human Infection challenge studies with RSV -- Human challenge studies with coronaviruses old and new -- Experimental urethral infection with Neisseria gonorrhoeae -- Helicobacter pylori.-Controlled human infection with Bordetella pertussis Human challenge studies for cholera -- The Controlled Human Infection Model for Enterotoxigenic Escherichia coli -- Challenges in developing a controlled human tuberculosis challenge model -- Shigella Controlled Human Infection Models: Current and Future Perspectives -- The background, role and outline approach for development of a Controlled Human Infection Model for Nontyphoidal Salmonella -- Controlled Human Malaria Infection studies in Africa - past, present, and future -- Controlled infection of humans with the hookworm parasite Necator americanus to accelerate vaccine development.
520 _aThis volume offers insights into human challenge studies, where adult volunteers are deliberately infected with a pathogen of interest. These studies can broaden our knowledge on infections that have a rather low natural infection rate, but still bear a great threat to global health. The authors also present instances, where no suitable animal model is available to help understand human immune responses to a specific pathogen. The recent SARS-CoV-2 pandemic is another example, where studies that are directly conducted in humans, could save valuable time. Human challenge studies can provide immunogenicity and early efficacy data for vaccine development. However, similar models could be used for studying a wide variety of medical treatments such as monoclonal antibodies, antibiotics, antivirals and bacteriophages. The chapters in this volume cover several pathogens, including viruses, bacteria and parasites, scientific and technical aspects as well as descriptions of regulatory, ethical and manufacturing requirements. The book serves as a valuable resource for scientists and clinicians working on human pathogens.
650 0 _aImmunology.
_969214
650 0 _aMedical microbiology.
_963858
650 0 _aMedicine
_xResearch.
_962598
650 0 _aBiology
_xResearch.
_965629
650 0 _aDiseases
_xCauses and theories of causation.
_978871
650 1 4 _aImmunology.
_969214
650 2 4 _aMedical Microbiology.
_963858
650 2 4 _aTranslational Research.
_970704
650 2 4 _aPathogenesis.
_978872
700 1 _aBagnoli, Fabio.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_986682
700 1 _aDel Giudice, Giuseppe.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_986683
700 1 _aPhogat, Sanjay K.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_986684
700 1 _aRappuoli, Rino.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_986685
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031631177
776 0 8 _iPrinted edition:
_z9783031631191
776 0 8 _iPrinted edition:
_z9783031631207
830 0 _aCurrent Topics in Microbiology and Immunology,
_x2196-9965 ;
_v445
_986686
856 4 0 _uhttps://doi.org/10.1007/978-3-031-63118-4
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c64531
_d64531